BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37166316)

  • 1. Association of
    Özkan-Kotiloğlu S; Kaya-Akyüzlü D; Yalçın-Şahiner Ş; Ayaz N
    Pharmacogenomics; 2023 Apr; 24(6):325-334. PubMed ID: 37166316
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of PDYN and OPRK1 polymorphisms on the risk of alcohol use disorder and the intensity of depressive symptoms.
    Özkan-Kotiloğlu S; Kaya-Akyüzlü D; Yurdakul R; Yıldırım MA; Özgür-İlhan İ
    Alcohol Alcohol; 2023 Jul; 58(4):404-414. PubMed ID: 37177778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
    Zhang Q; Shi M; Tang H; Zhong H; Lu X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
    [No Abstract]   [Full Text] [Related]  

  • 4. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
    Yuferov V; Butelman ER; Randesi M; Ott J; Kreek MJ
    Neurosci Lett; 2022 Jan; 768():136364. PubMed ID: 34843875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population.
    Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P
    J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.
    Jones JD; Luba RR; Vogelman JL; Comer SD
    Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of genetic polymorphisms in the κ-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance.
    Wang SC; Tsou HH; Chung RH; Chang YS; Fang CP; Chen CH; Ho IK; Kuo HW; Liu SC; Shih YH; Wu HY; Huang BH; Lin KM; Chen AC; Hsiao CF; Liu YL
    J Clin Psychopharmacol; 2014 Apr; 34(2):205-11. PubMed ID: 24525640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of genetic association in opioid dependence susceptibility.
    Nagaya D; Zahari Z; Saleem M; Yahaya BH; Tan SC; Yusoff NM
    J Clin Pharm Ther; 2018 Feb; 43(1):80-86. PubMed ID: 28656735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
    Kumar D; Chakraborty J; Das S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.
    Yuferov V; Fussell D; LaForge KS; Nielsen DA; Gordon D; Ho A; Leal SM; Ott J; Kreek MJ
    Pharmacogenetics; 2004 Dec; 14(12):793-804. PubMed ID: 15608558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use.
    Kaya-Akyüzlü D; Özkan-Kotiloğlu S; Yalçın-Şahiner Ş; Ağtaş-Ertan E; Özgür-İlhan İ
    Eur J Pharmacol; 2022 Apr; 921():174862. PubMed ID: 35271823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk.
    Xu K; Seo D; Hodgkinson C; Hu Y; Goldman D; Sinha R
    Transl Psychiatry; 2013 Aug; 3(8):e292. PubMed ID: 23962922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states.
    Karpyak VM; Winham SJ; Preuss UW; Zill P; Cunningham JM; Walker DL; Lewis KA; Geske JR; Colby CL; Abulseoud OA; Hall-Flavin DK; Loukianova LL; Schneekloth TD; Frye MA; Bazov I; Heit JA; Bakalkin G; Mrazek DA; Biernacka JM
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):975-85. PubMed ID: 23101464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of miRNA-144-3p/Oprk1/KOR in nicotine dependence and nicotine withdrawal in male rats.
    Shao J; Fei Y; Xiao J; Wang L; Zou S; Yang J
    Nicotine Tob Res; 2023 Nov; 25(12):1856-1864. PubMed ID: 37455648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history.
    Proudnikov D; Randesi M; Levran O; Yuferov V; Crystal H; Ho A; Ott J; Kreek MJ
    J Acquir Immune Defic Syndr; 2013 May; 63(1):17-26. PubMed ID: 23392455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
    Ashenhurst JR; Bujarski S; Ray LA
    Pharmacol Biochem Behav; 2012 Dec; 103(2):253-9. PubMed ID: 22954510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype-based association study of Opioid Receptor Kappa-type 1 (OPRK1) gene polymorphisms with nicotine dependence among male smokers.
    Albonaim A; Sharafshah A; Keshavarz P
    Br J Biomed Sci; 2021 Jul; 78(3):151-153. PubMed ID: 32508243
    [No Abstract]   [Full Text] [Related]  

  • 18. Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction.
    Gerra G; Leonardi C; Cortese E; D'Amore A; Lucchini A; Strepparola G; Serio G; Farina G; Magnelli F; Zaimovic A; Mancini A; Turci M; Manfredini M; Donnini C
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):771-5. PubMed ID: 17373729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder.
    Kaya-Akyüzlü D; Özkan-Kotiloğlu S; Danışman M; Bal C; Oğur B; İspir GZ
    Environ Toxicol Pharmacol; 2023 Jun; 100():104143. PubMed ID: 37146669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the kappa-opioid system with alcohol dependence.
    Xuei X; Dick D; Flury-Wetherill L; Tian HJ; Agrawal A; Bierut L; Goate A; Bucholz K; Schuckit M; Nurnberger J; Tischfield J; Kuperman S; Porjesz B; Begleiter H; Foroud T; Edenberg HJ
    Mol Psychiatry; 2006 Nov; 11(11):1016-24. PubMed ID: 16924269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.